Medley, Inc (MDLYF) Fair Value & Analysis
Healthcare · US · Market cap $406M
Fair value as of: Jun 24, 2026
Analysis
Medley, Inc (MDLYF) currently trades at $13.52, while our model-based Fair Value estimate is $5.00 — implying the stock looks roughly 63.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Medley, Inc. operates platforms for recruitment and medical businesses in Japan and the United States. It operates through three segments: Human Resources Platform Business, Medical Platform Business, and New Development Services. The company manages JobMedley, a human resource recruitment system for medical and healthcare, and related businesses; JobMedley Academy, an online video nursing training service; Medley, an electronic medical records for hospitals; Mall, a cloud dental business support system; Dentis, a cloud based dental clinic supports system; CLINICS Telemedicine, a telemedicine system for patients and medical institutions; CLINICS, a cloud medical support system; Pharms, pharmacy window support systems; Lalune, a women health consultation application; and Jobley for job board. It also operates and provides the facility reservation system @link. The company was incorporated in 2009 and is headquartered in Minato, Japan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Medley, Inc (MDLYF) undervalued?
What is the fair value of MDLYF?
What is the quality score of MDLYF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.